Further news
As the only Hungarian diagnostic service provider KPS Molecular Diagnostics scored 100% at KRAS European External Quality Assessment Schemes 2010 organized by the European Society of Pathologists. Samples for the KRAS European external More»
KPS Molecular Diagnostics has been chosen as a key genomic infrastructure provider in the Central-European Region. The University of Birmingham published the list "Next Generation Genomics: World Map of High-throughput More»
Our genome sequencing laboratory and our Roche FLX Genome Sequencer FLX System was certified as a strategic research infrastructure by the National R&D Infrastructure Survey in this month. The Hungarian National R&D Infrastructure More»
In July, Nature Reviews Drug Discovery will publish our CEO's paper about the chances of development of novel drug compounds and targeted therapy in the future. In the 1990s, the breast cancer drug trastuzumab (Herceptin; Genentech/Roche) More»
